Male Contraceptive Drug Development Using a Novel Human Sperm Phenotypic Screening Platform (Grand Challenges Phase II)

StatusActive
Effective start/end date1/11/1831/10/20

Funding

  • Bill and Melinda Gates Foundation (OPP1203050): £709,904.00